Laurie Villanueva

Laurie Villanueva has been writing about consumer issues for over two decades, Her work for largely focuses on pharmaceutical and medical device safety, including the ongoing litigation surrounding Risperdal, proton pump inhibitors, Invokana, Levaquin, defective hip implants, the Bair Hugger forced air warming blanket, and IVC filters. Laurie has also devoted a great deal of coverage to women’s health issues, especially recent litigation involving talcum powder, power morcellators, transvaginal mesh, and breast implants.

Laurie graduated from Penn State University in 1990 with a degree in journalism. After spending many years covering local government for various print media outlets, she is now focused on utilizing the internet to raise awareness about important consumer issues.

Avet Pharmaceuticals Faces Lawsuit Over Contaminated Metformin

Heritage Pharmaceuticals, which does business as Avet Pharmaceuticals, Inc., is facing allegations that its generic metformin tablets contain high levels of a cancer-causing impurity. According to Bloomberg Law, this latest metformin lawsuit was filed on March 30th in the U.S … Continue reading

Zantac Lawsuit News: Federal Court Reschedules Initial Conference, Plaintiffs Leadership Interviews

The federal court overseeing dozens of Zantac lawsuits has rescheduled the litigation’s Initial Conference and plaintiffs’ leadership interviews, both of which were postponed due to the global coronavirus pandemic. Initial Conference Set for May 12, 2020 According to an Order … Continue reading

Zantac Lawsuit Court Establishes Procedures for Implementing Census

Dozens of Zantac lawsuits continue to move forward in the U.S. District Court, Southern District of Florida, despite the suspension of all in-person proceedings due to the ongoing coronavirus pandemic. Zantac Lawsuits Will Undergo 2-Phase Census According to an Order … Continue reading

Johnson & Johnson Talcum Powder Trials on Hold Amid Coronavirus Pandemic

At least a half-dozen trials involving Johnson & Johnson’s talcum powder products have been postponed in recent days, as the ongoing coronavirus pandemic continues to impact legal proceedings around the United States. The postponements include Brower v Johnson & Johnson, … Continue reading

Coronavirus Pandemic Delays Monsanto Roundup Settlement Talks

The global coronavirus pandemic is delaying negotiations aimed at settling thousands of Monsanto Roundup lawsuits that blame glyphosate for causing cancer. According to The New York Time, Bayer AG’s CEO and Kenneth Feinberg – the prominent attorney tapped to led … Continue reading

FDA Orders Immediate Zantac Recall, Confirms NDMA Contamination

The U.S. Food & Drug Administration (FDA) has ordered the immediate removal of all Zantac and ranitidine products from the market, after its investigation confirmed that a potentially cancer-causing contaminant may increase over time. The confirmation will likely bolster claims … Continue reading

Kentucky Woman Blames NDMA in Zantac for Stomach & Liver Cancer

A Kentucky woman who was diagnosed with stomach and liver cancer following years of Zantac use is suing the manufacturers of the popular heart burn medication. Zantac Cancer Lawsuit Allegations According to a March 6th filing in the U.S. District … Continue reading

Uloric Lawsuits Mount, With New Filing in Illinois Federal Court

Lawsuits involving Uloric continue to mount in the wake of last year’s U.S. Food & Drug Administration (FDA) warning on the serious side effects potentially associated with Takeda Pharmaceutical’s popular gout treatment. Uloric Heart Attack Allegations One of the latest … Continue reading

Bayer Agrees to Settle Monsanto Roundup False Ad Lawsuit

More than two years after completing its acquisition of Monsanto, Bayer AG has agreed to pay $39.5 million to settle a false advertising lawsuit involving its controversial Roundup weed killer. The settlement, which was filed in federal court in Kansas … Continue reading

Belviq Lawsuit Alleges Weight Loss Drug “Substantially” Increases Risk of Cancer

The manufacturers of Belviq are facing a new lawsuit over the medication’s alleged link to cancer. The complaint, which was filed on March 27th in the U.S. District Court, Southern District of New York, seeks class action status on behalf … Continue reading

Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest